Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03267186
Title Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant
Recruitment Completed
Gender
Phase Phase II
Variant Requirements No
Sponsors Andrew Rezvani
Indications
Therapies
Age Groups:
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University, School of Medicine Palo Alto California 94304 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field